Yu Xue
No. 3 Xingyuan Road
Shijiazhuang, 050200, China
Shijiazhuang, 050200, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
YAP1 suppression inhibits autophagy and improves the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma.
Journal: Experimental cell research
Published: November 20, 2022
Dihydroartemisinin increased the abundance of Akkermansia muciniphila by YAP1 depression that sensitizes hepatocellular carcinoma to anti-PD-1 immunotherapy.
Journal: Frontiers of medicine
Published: October 07, 2022
Integrated analysis of transcriptomics and metabolomics in human hepatocellular carcinoma HepG2215 cells after YAP1 knockdown.
Journal: Acta histochemica
Published: June 26, 2022
Dihydroartemisinin broke the tumor immunosuppressive microenvironment by inhibiting YAP1 expression to enhance anti-PD-1 efficacy.
Journal: Phytotherapy research : PTR
Published: April 15, 2022
Dihydroartemisinin inhibited the Warburg effect through YAP1/SLC2A1 pathway in hepatocellular carcinoma.
Journal: Journal of natural medicines
Published: October 04, 2021
Dihydroartemisinin reduced lipid droplet deposition by YAP1 to promote the anti-PD-1 effect in hepatocellular carcinoma.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: July 18, 2021
The Effects of Qinghao-Kushen and Its Active Compounds on the Biological Characteristics of Liver Cancer Cells.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: July 17, 2021
Solute carrier family 2 members 1 and 2 as prognostic biomarkers in hepatocellular carcinoma associated with immune infiltration.
Journal: World journal of clinical cases
Published: April 21, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026